The phytopathological disease diagnostics market is anticipated to climb at a CAGR of 4.5% from 2024 to 2034. In 2024, the industry is valued at around USD 105.2 million, which shows the spike in demand for diagnostics solutions for eliminating the impact of plant diseases on agricultural productivity.
Nonetheless, the sector is anticipated to show a remarkable jump, and by 2034, it is estimated to generate more than USD 163.4 million. This growth is linked to the ongoing integration of advanced diagnostic technologies in agricultural laboratories, academic institutions, and crop protection companies for the aim of controlling and monitoring phytopathological diseases.
Higher investments in research and development, which suites to develop new diagnostic methods and produce innovative solutions for the fighting of the rising plant pathogens, should also contribute to the growth of the market over the forecast period.
The inclining demand trend is further caused by the rising phytosanitary diseases globally due to climatic change, globalization of trade, and different agricultural practices.
With these diseases presenting a huge threat to crop yields and food security, early detection, and rapid diagnosis are being emphasized, thereby increasing the demand for diagnostics and innovations in technologies to be successful.
The continuous increase in the farmer's and growers' awareness of the importance of early disease detection and prevention measures is the primary driver of the application of phytopathological disease diagnostics.
With the rise of sustainable agriculture and integrated pest management technologies, the need for diagnostics tools to make informed decisions on crop protection and disease management strategy has become more pronounced.
Furthermore, government programs and regulations that focus on plant health and food safety are also expected to be the significant drivers of this expansion. Apart from that, the development of imaging and diagnostic techniques such as molecular assays and high-throughput screening is also improving the accuracy and speed of disease diagnosis, resulting in new opportunities for players.
| Attributes | Description |
|---|---|
| Estimated Global Phytopathological Disease Diagnostics Market Size (2024E) | USD 105.2 million |
| Projected Global Phytopathological Disease Diagnostics Market Value (2034F) | USD 163.4 million |
| Value-based CAGR (2024 to 2034) | 4.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Use of DNA Barcoding Picking Up in Accurate Disease Identification
The phytopathological disease diagnostics industry is witnessing a surge in the adoption of DNA barcoding, a technique used for pinpointing organisms in high precision through the use of short, standardized gene sequences.
This allows rapid and high-accuracy detection of plant pathogens. Consequently, the technique will empower farmers and agricultural professionals to use targeted treatment strategies that will avoid unnecessary use of broad-spectrum fungicides.
Mobile Apps Debut for On-Field Disease Detection
Mobile apps are now replacing the very painstaking process of transporting samples to laboratories. User-friendly mobile applications capable of recognizing an image will soon hit the market.
Through these applications, farmers can take images of affected plants in the field. Analysis of these images by the app will provide potential diagnoses that can allow informed decisions about disease management right at the point of detection.
Biosensors for Health Continuous Monitoring
Continuous monitoring, based on biosensor technology is likely the future of plant health management. The sensors are being devised for early symptom and sign detection of diseases by continuous monitoring of physiological parameters like plant respiration or chemical imbalances.
In turn, the detection of early diseases allows timely intervention and, hence, a reduction in crop losses, which permits improved agricultural efficiency.
Quicker and More Accurate Diagnostic Results Using AI
Artificial intelligence has penetrated most scientific fields for a long time, and phytopathological diagnostics should not be an exception.
Indeed, nowadays, AI algorithms are gradually entering modern diagnostic systems that analyze data from numerous sources, including images and sensor readings. All this facilitates quicker and more accurate identification for a faster response to outbreaks and better disease control.
The Rise of Remote Sensing for Large-Scale Disease Tracking
Surveillance for the presence of disease in large fields has been an expensive affair. This is likely to change with the use of drones and satellite remote sensing. The techniques capture high-resolution aerial images of a large area, showing subtle differences in plant health, which will enable the identification of plant disease occurrence and prediction of outbreaks.
This has unlocked large-scale disease surveillance that could predict the possibility of outbreaks, thus facilitating proactive disease management.
Nanotechnology Permits Controlled Release of Pesticides
Nanotechnology is one such area that is promising to provide precision and to be eco-friendly in the management of pests. Research is being carried out to develop nanoparticles, which encapsulate pesticides in a way that allows them to be directly delivered into infected plant tissues.
This approach, again, not only saves the amount of pesticide applied in total to achieve a desired effect but also reduces harm to beneficial insects and environmental systems and brings sustainable changes to the agricultural landscape.
Biocontrol Demand for Eco-Friendly Diagnostics Spurs Biocontrol Growth
With a growing emphasis on sustainability, farmers are increasingly looking for green alternatives in plant disease management. This drives the biocontrol agents market for natural organisms or compounds that can suppress plant pathogens. It will further drive the trend with an increased use of eco-friendly diagnostics tools, for the ability to identify the right biocontrol solutions by the disease.
The global phytopathological disease diagnostics sector has exhibited a trend of continuous growth, with a CAGR of 4% from 2019 to 2023. This phenomenon is brought about by the influence of several major driving forces.
Farmers, as the ones who are familiar with the losses of crops caused by plant diseases, are switching from traditional techniques to using advanced tools for early disease detection and more efficient management.
The development of precise agriculture, the branch of agriculture that uses data for better decision-making, has resulted in a sharp growth in the demand for precise disease diagnostics. Last but not least, government incentives advocating sustainable agricultural practices have contributed a lot to the rise of the sector that was rooted in green diagnostic tools.
By 2034, the phytopathological disease diagnostics demand outlook appears quite promising, and a CAGR of 4.5% is forecasted. On the other hand, better technologies might be the reason for the more gradual growth.
As discussed in the trends section, new technologies, like AI, biosensors, and DNA barcoding, are being incorporated into tools for diagnosis that are faster, more precise, and more user-friendly, and they hold the promise of more efficient disease identification.
Also, an accelerating adoption of subscription-based services that deliver long-term disease management and expert consulting is expected to be the main driving force behind growth. In addition, the increasing attention to ecological agriculture approaches will contribute to the consumption extension of biocontrol agents and diagnostic tools, which are designed for their targeted usage.
Moving to sustained growth is not without its own possible barriers. An economic downturn may put a brake on technological investments in agriculture, and this slowdown may be one of the hindrances to expansion.
Supply chain disruptions that lead to difficulties in the distribution and affordability of diagnostic tools are also a potential issue. The appearance of unpredicted plant diseases may force the diagnostic tools to be changed quickly, which may be a source of further risks to the stability of markets.
Principal Consultant
The phytopathological disease diagnostics industry witnesses a spike in demand in India and China. Hence, these countries are forecast to offer new players and established companies plenty of opportunities to expand or thrive. Meanwhile, industries in the United States, the United Kingdom, and Germany are moving steadily toward maturation with an average CAGR of 3% over the forecast period.
Countries CAGR 2024 to 2034 United States 3.9% United Kingdom 2.2% Germany 3.1% India 6% China 5.1% Phytopathological Disease Diagnostics Companies in the United States Turn Toward Consistent Innovation The United States remains a leader in the agriculture sector, with its market for phytopathological disease diagnostics expected to hold a constant 3.9% CAGR through 2034.
This is expected, given the country's pace of development in agriculture through consistent and dedicated investment in agricultural research and development. Significant among the observations is the regular investment that the nation keeps making in agricultural research and development, with advancements made more routinely through biosensors and artificial intelligence-driven diagnostics that possibly hold new promises for more accurate and efficient disease identification.
However, it is already placed in the infrastructure for controlling diseases compared to developing countries in the USA agricultural sector. Additionally, basic diagnostic tools will have a potentially higher rate of saturation in the USA sector, requiring stronger value propositions for such tools to the farmers using these technologies. United Kingdom Braces for A Measured Approach Amidst Existing Infrastructure The United Kingdom represents a CAGR of 2.2%, a more measured and cautious reflection of growth in the phytopathological disease diagnostics sector.
The country has the same base as the United States, as there have been long-established, well-defined measures for disease control and a tradition of strong agricultural practices. Although there will be significant penetration of advanced diagnostics into the market, the extent of transition may not be as rapid as for emerging economies.
Such a measured approach is likely because of reasons such as a cost-sensitive approach and because proper maintenance of existing facilities is on the backbone of the agricultural sector in the UK However, ongoing research, coupled with an increasing focus on sustainable farming, is set to propel this industry toward more advanced diagnostic technologies in the long run. India Turns into A Market Primed for Untapped Opportunities India is growing to become one of the potential countries for companies having a CAGR of 6% through 2034.
The reasons for such exponential growth are many and peculiar to the agricultural state of affairs in India. First, agriculture is one of the major support systems of the Indian economy, and early and accurate disease detection is required to protect the large population from hunger and malnutrition. Second, Indian farmers are also becoming increasingly aware that plant diseases are responsible for huge economic losses; therefore, there is a swift movement towards advanced diagnostic tools.
This is not so in developed economies, like the USA and UK, where the existing infrastructure and practices would require a less drastic move toward diagnostic approaches. Better disposable income among farmers and a growing middle class further consolidate potential in the market, giving enough room for these technologies to grow.
The conjuncture of these factors makes India a market ripe for exponential growth in the phytopathological disease diagnostics sector in the coming decade.
By product type, kits emerge as the most popular sales magnet segment with a dominant share in 2024. Also, by test type, the serological tests turn into a potential business driver for companies during the forecast period.
| Segment | Kits (Product Type) |
|---|---|
| Value Share (2034) | 43.4% |
Among the products in the category, diagnostic kits are the most dominant, with a market share of 43.4% by 2024. The kits in the diagnostic kit category go beyond being just a comprehensive and user-friendly strategy for diagnosing disease.
Generally, the kits have everything that is needed for testing on the site, like reagents, devices, and instructions, and these are pre-packaged, which makes the diagnosing process simpler for farmers and agricultural experts. The instrumentalization of user-friendliness implies a positive impact, especially on people with low familiarity with laboratory procedures.
This flexibility in the use of these kits in several disease types makes them a valuable product to address different issues related to crop production.
Growers can opt for sets that are tailored to the types of crops they produce and the diseases they are mostly worried about. The selective strategy significantly reduces the waste of resources while increasing the efficiency of disease management.
| Segment | Serological Tests (Test Type) |
|---|---|
| Value Share (2034) | 58.1% |
By test types, serological tests are leading with a notable share of 58.1% in 2024. These tests, in turn, focus on the detection of antibodies, which are products of the plant’s immune system, in response to specific types of pathogens.
Their efficacy resides in their possibility to detect a disease even in a few minutes so that it can be stopped in its tracks and the crops can be protected from further spread. The timely identification of the disease at this stage is what is required for the implementation of the management measures and reduction of the losses in yield.
Moreover, as a rule, serological tests are usually inexpensive compared with other diagnostic methods and, therefore, serological tests are a cost-effective option for farmers of all scales.
The anticipated widespread use of serological tests puts them in a position to become a key driving force for companies in the diagnostic sub-field of phytopathological diseases. Such a capability of making tests cheaper and faster could be a key competitive advantage in the market of diagnostics.
Moreover, the continuous progress in serological technology, like the invention of multiplex tests that can simultaneously detect pathogens could significantly increase the efficiency of this section in the near future.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The competitive scenario of the phytopathological disease diagnostics industry is anticipated to turn difficult for startups as significant players battle for market share. Established companies are likely to employ several different tactics to hold their places.
Firstly, the ongoing research and development efforts will be the vital stepping stone for the development of advanced diagnostic tools, which will provide greater accuracy, speed, and ease of use.
In the second place, cooperative arrangements with agricultural research institutions and seed enterprises can be of great essence as they will ensure that the product is in the market and also enable the development of tailored solutions for individual crops and diseases.
In the end, well-established companies have a chance to use their distribution chains and brand names as their financial tools in order to remain competitive.
New players, on the other hand, may pose a threat by discarding the conventional and expensive diagnostic methods and by creating less expensive and user-friendly tools.
Moreover, the company can give special attention to niche areas or the implementation of the bio-sensors technology that may help to differentiate itself from competitors. Collaborations among established players and tech startups can give rise to a more vibrant and competitive market. Such a scenario is likely to promote rapid progress and a diversity of solutions for agripreneurs worldwide.
Industry Updates
Product segments in the industry include kits such as ELISA kits, DNA-based diagnostics kits, and protein-based diagnostics kits. Additionally, there are lateral flow devices, DNA/RNA probes, and accessories and other consumables. software and cloud databases are also part of this category.
Test segments encompass molecular tests, which consist of PCR-based assays, PCR & RT-PCR, and multiplex PCR. isothermal amplification assays, microarray assays, NASBA, and LAMP assays are also included. serological tests, like ELSIA, TBIA, and QCMI, along with tests using electronic technology, complete this category.
Sample types for testing include seeds, grains, plants, trees, and fruits.
End users of these products and tests can be agricultural laboratories, academic and research institutes, food processing laboratories, contract research organizations, and others who utilize these tools and technologies for various purposes.
The industry is segmented by regions which are North America, Latin America, Europe, East Asia, South Asia and Pacific, and the Middle East and Africa.
The industry is estimated to reach USD 105.2 million in 2024.
Sales are poised to rise at a 4.5% CAGR by 2034.
The industry is set to reach USD 163.4 million in 2034.
Some players are ThermoFischer Scientific, Clear Detections B.V, and Merck KGaA.
Kits segment is estimated to hold a prominent share in 2024.
1. Executive Summary 2. Industry Introduction, Including Taxonomy and Market Definition 3. Market Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, Including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Product 6.2. Test 6.3. Sample Type 6.4. End User 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 7.1. Kits 7.1.1. ELISA Kits 7.1.2. DNA-based Diagnostics Kits 7.1.3. Protein-based Diagnostics Kits 7.2. Lateral Flow Devices 7.3. DNA/RNA Probes 7.4. Accessories & Consumables 7.5. Software and Cloud Databases 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test 8.1. Molecular Tests 8.1.1. PCR-based Assays 8.1.1.1. PCR & RT-PCR 8.1.1.2. Multiplex PCR 8.1.2. Isothermal Amplification Assays 8.1.2.1. Microarray Assays 8.1.2.2. NASBA 8.1.2.3. LAMP Assays 8.2. Serological Tests 8.3. ELISA 8.4. TBIA 8.5. QCMI 8.6. Tests Using Electronic Technology 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sample Type 9.1. Seeds 9.2. Grains 9.3. Plants 9.4. Trees 9.5. Fruits 9.6. Others 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 10.1. Agricultural Laboratories 10.2. Academic and Research Institutes 10.3. Food Processing Laboratories 10.4. Contract Research Organizations 10.5. Others 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 11.1. North America 11.2. Latin America 11.3. Western Europe 11.4. South Asia 11.5. East Asia 11.6. Eastern Europe 11.7. Middle East & Africa 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 19. Sales Forecast 2024 to 2034 by Product, Test, Sample Type, and End User for 30 Countries 20. Competition Outlook, Including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 21. Company Profile 21.1. Thermo Fisher Scientific Inc. 21.2. Clear Detections B.V. 21.3. Merck KGaA 21.4. Agdia, Inc. 21.5. Qualiplante SAS 21.6. LOEWE Biochemica GmbH 21.7. BIOREBA AG 21.8. PanonIT 21.9. Agrisera AB 21.10. Biosense Laboratories AS 21.11. OptiGene Limited 21.12. TwistDx Limited
Explore Healthcare Insights
View Reports
Phytopathological Disease Diagnostics Market
